HGSI

The short interest data is out from the July 13 settlement date and we have compared these levels to the prior June 29 settlement date. It seems that there were some big changes with some key cult...
Jon C. Ogg
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall S. research calls this Monday morning.Biogen Idec Inc. (NASDAQ: BIIB) started as Outperform at...
Jon C. Ogg
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Tuesday.Alcatel-Lucent SA (NYSE: ALU): Cut to Hold at Deutsche...
Jon C. Ogg
The three major US stock indexes opened lower this morning following some lackluster data on the US economy. The Empire State manufacturing data improved, but retail sales posted an unexpected...
Paul Ausick
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s news...
Jon C. Ogg
Subject: America’s Biggest Advertisers The 10 largest advertisers in the United States spent $26.2 billion in 2011, according to Advertising Age, an advertising trade publication. While the number...
Stuart Stelzer
Updated throughout the day on the 24/7 Wall St. Wire:GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters)The Justic Department and HSBC (NYSE: HBC)...
Douglas A. McIntyre
Much of the financial future of Europe is still caught in a web of the political movements of Germany’s Angela Merkel. Today, the possibility that her own party will not support a Spanish bank...
Douglas A. McIntyre
GlaxoSmithKline (NYSE: GSK) will take over Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters)A poll from the National Association for Business Economics shows few companies plan to...
Douglas A. McIntyre
The short interest data is out from the June 29 settlement date.  It seems that there were some big changes with some key cult stocks and actively traded stocks seeing big changes over the June 15...
Jon C. Ogg
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
Jon C. Ogg
Some wireless companies oppose the use of their networks as a means to make political contributions. (Reuters)Chinese inflation falls as the nation’s economy cools. (Reuters)The push to put...
Douglas A. McIntyre
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
Jon C. Ogg
The short interest data is out using the June 15 settlement date and we have compared this to the May 31 settlement date and prior periods for a comparison.  With choppy markets in June after a...
Jon C. Ogg
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday.  We also have many changes to the Argus Model Portfolio.ABB...
Jon C. Ogg